Evidence map›Paper›PMID 30830860›Full record

ArticleJCI insight2019

GPR55 controls functional differentiation of self-renewing epithelial progenitors for salivation.

Solomiia Korchynska, Mirjam I Lutz, Erzsébet Borók, Johannes Pammer, Valentina Cinquina, Nataliya Fedirko, Andrew J Irving, Ken Mackie, Tibor Harkany, Erik Keimpema

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 6 countries.

Solomiia KorchynskaDepartment of Molecular Neurosciences, Center for Brain Research.
Mirjam I LutzInstitute of Neurology.
Erzsébet BorókDepartment of Molecular Neurosciences, Center for Brain Research.
Johannes PammerDepartment of Pathology, Medical University of Vienna, Vienna, Austria.
Valentina CinquinaDepartment of Molecular Neurosciences, Center for Brain Research.
Nataliya FedirkoDepartment of Human and Animal Physiology, Biological Faculty, Ivan Franko National University of Lviv, Lviv, Ukraine.
Andrew J IrvingSchool of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland.
Ken MackieGill Center for Biomolecular Sciences, Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, USA.
Tibor HarkanyDepartment of Molecular Neurosciences, Center for Brain Research.
Erik KeimpemaDepartment of Molecular Neurosciences, Center for Brain Research.
Allen Institute for Brain Science · USIndiana University Bloomington · USLviv University · UAMedical University of Vienna · ATUniversity College Dublin · IE

Funding

Cannabinoid Modulation of Cell FunctionK05DA021696 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI MACKIE, KENNETH · 2007 to 2017
$1.3M
NIDA NIH HHS K05 DA021696
6 · The paper itself

Abstract

GPR55, a lipid-sensing receptor, is implicated in cell cycle control, malignant cell mobilization, and tissue invasion in cancer. However, a physiological role for GPR55 is virtually unknown for any tissue type. Here, we localize GPR55 to self-renewing ductal epithelial cells and their terminally differentiated progeny in both human and mouse salivary glands. Moreover, we find GPR55 expression downregulated in salivary gland mucoepidermoid carcinomas and GPR55 reinstatement by antitumor irradiation, suggesting that GPR55 controls renegade proliferation. Indeed, GPR55 antagonism increases cell proliferation and function determination in quasiphysiological systems. In addition, Gpr55-/- mice present ~50% enlarged submandibular glands with many more granulated ducts, as well as disordered endoplasmic reticuli and with glycoprotein content. Next, we hypothesized that GPR55 could also modulate salivation and glycoprotein content by entraining differentiated excretory progeny. Accordingly, GPR55 activation facilitated glycoprotein release by itself, inducing low-amplitude Ca2+ oscillations, as well as enhancing acetylcholine-induced Ca2+ responses. Topical application of GPR55 agonists, which are ineffective in Gpr55-/- mice, into adult rodent submandibular glands increased salivation and saliva glycoprotein content. Overall, we propose that GPR55 signaling in epithelial cells ensures both the life-long renewal of ductal cells and the continuous availability of saliva and glycoproteins for oral health and food intake.

Indexed as

AdultAdult Stem CellsAgedAged, 80 and overAnimalsCannabinoid Receptor AgonistsCannabinoid Receptor AntagonistsCarcinoma, MucoepidermoidCell DifferentiationCell Self RenewalDown-RegulationEpithelial CellsFemaleGlycoproteinsHumansMaleCannabinoid Receptor AgonistsCannabinoid Receptor AntagonistsGlycoproteinsGPR55 protein, humanGPR55 protein, mouseReceptors, CannabinoidEndocrinologyGastroenterologyG-protein coupled receptors

Identifiers

PMID30830860
PMCPMC6478415
OpenAlexW2917673320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.